PF-Atlas › Clinical Trials › NCT04010253
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
SIMEOX · Not specified
Registry ID
NCT04010253
Phase
Not specified
Status
Completed
Drug / intervention
SIMEOX
Sponsor
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Start
2019-09-30
Enrollment
31
Locations
8
About this trial
The main objective of the study is to evaluate the short-term effects of the airway clearance technique by the medical device Simeox (Physio Assist, France) versus Autogenic Drainage, on the pulmonary function of adult patients with stable cystic fibrosis. To analyse these effects, the investigators used forced oscillation technique measured by TremoFlo™ C-100 Airwave Oscillometry System™ (THORASYS Thoracic Medical Systems Inc. Montreal, Quebec, Canada) with an evaluation of the perceived clinical benefits.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT04010253 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.